GV
About GV
GV is a venture capital firm that supports innovative founders moving the world forward, with a focus on consumer, enterprise, life sciences, and frontier tech sectors.
Recent News
Isomorphic Labs Raises $2.1 B to Expand AI-Driven Drug Discovery Platform
FinTech Funding Continues Strong Run with over $800m Raised This Week
Parabilis Heads Biotech Fundraising Frenzy With $305M to Advance Cancer Drug
Flick Raises $6M for Filmmaker-First AI Video Tools
Syremis Therapeutics Raises $165M in Series A Financing
Pinterest Alternative Cosmos Is Looking to Redefine Visual Inspiration for Creatives
Sierra Raises $950M as the Race to Own Enterprise AI Gets Serious
Alphabet's Isomorphic Labs Raises $2.1 Billion to Scale AI Drug Discovery Toward Clinical Trials
Omni Scoops Up $120M at $1.5B Valuation
GV-Backed Biotech Startup OMass Faces IP Lawsuit
Makary Resigns, BMS Bets $15B on China R&D, and Regenxbio Wins Phase 3 in Duchenne – This Week in Biotech #100
Lawhive Closes $60M Series B for Consumer Legal AI
Investors Share What to Remember While Raising a Series A
Menlo Partner Deedy Das Says Wealth Won’t Cure Silicon Valley Founder Blues
Flourish Raises $500 Million Series B, Valued at $2.5 B to Build Brain‑Inspired AI
Nectar Social Secures $30M Series A to Scale AI‑Powered Marketing OS
Signos Grows Foothold in Weight Loss Wave Fueled by GLP-1s with Its AI Health Data Tracking
Sierra Secures $950 Million Funding, Valued at $15 Billion to Scale AI‑Driven CX Platform
Recursive Superintelligence Secures $650M Seed Round at $4.65B Valuation
The Week’s 10 Biggest Funding Rounds: XAI Leads As 2026 Is Off To A Brisk Start
OpenEvidence Brings Hands-Free Medical AI to 860,000 Clinicians
Synthesia Announces Major Hiring Push, Opens Three New Offices
Isomorphic Labs Pulls $2.1B Series B Led By Thrive With MGX, Temasek, And UK Sovereign AI Fund: What The Capital Stack, IsoDDE Engine, And Novartis/Lilly/J&J Partnerships Mean For Drug Discovery
Quiet Week for FinTechs with Just over $450m Raised in Total Deals
One-Time Hot Insurance Tech Ethos Poised to Be First Tech IPO of the Year
Synthesia Hits $4B Valuation, Lets Employees Cash Out
J&J Bets on Isomorphic for AI-Powered Drug Hunt
The Private Assets Held in Public Companies
AI-Powered Fragrance Company Osmo Raises $70 Million in Series B Funding
Delve Detect Enables Neurologists to Treat CNS Infections When Conventional Testing Fails
Syneron Raises $150m for Macrocyclics, and Other Financings
GV Backs MokN’s $15m Bid to Flip the Script on Phishing
SmallSat Europe Speaker Focus: Simon Van Den Dries, EnduroSat
Gate Bioscience Raises $65M in Series B Financing
Paradigm Health Raises $78M in Series B Funding
Omni Secures $120 Million Series C at $1.5 B Valuation, Led by ICONIQ
Uber-Backed Electric Scooter Rental Firm Lime Files for IPO
What Is Series Funding A, B, and C?
Wealth.com Nabs $65M Series B Round
Isomorphic Labs Raises $2.1 B Series B to Scale AI Drug‑Design Engine
Isomorphic Labs Secures $2.1 B Series B to Accelerate AI Drug Discovery
MokN Raises €12.9 Million to Combat Credential Theft as GV Makes Its First Investment in a French Startup
Prudentia Sciences Secures $20M Series A Financing
Lawhive Raises $60M in Series B Funding
Mandiant’s Founder Just Raised $190M for His Autonomous AI Agent Security Startup
AI Startup Sierra Secures $950 Million Funding, Nears $1 Billion Valuation
SolveAI Raises $50M to Help Employees Build Their Own Enterprise Software
EXCL: HMRC Signs £150k Deal for AI-Generated Comms and Training Videos
Isomorphic Raises $2.1bn for AI Drug Hunt
OpenEvidence, An AI-Powered ‘Brain Extender’ For Doctors, Doubles Valuation To $12B With $250M Series D
Recent Deals
Resistant AI Raises $25M Series B to Expand Fraud Prevention AI Internationally
Pelage Pharmaceuticals Closes $120M Series B Led by ARCH Venture Partners and GV
Odyssey Raises Series A Led by EQT Ventures
Synthesia Raises $200M in Latest Funding Round, Valuation Jumps to $4B
Gate Bioscience Secures $65M Series B Round Led by Forbion and Eli Lilly
Paradigm Health Secures $78M Series B Led by ARCH Venture Partners
EpiBiologics Raises $107M in Series B to Advance Protein-Degrading Cancer Drug
GV Leads $27M Series A Funding for Translucent, AI Healthcare Finance Platform
Syremes Therapeutics Secures $165M Series A to Advance Mental‑Health Drug Pipeline
Prudentia Sciences Raises $20M Series A Led by McKesson Ventures
Signos Raises $20M for Glucose Monitoring System for Weight Management
Navier Secures $5.6M Seed Funding to Launch Autonomous Engineering Teams
Pelage Pharmaceuticals Raises $120M in Series B Co-Led by ARCH and GV
Midi Health Secures $100M Series D Funding Led by Goodwater Capital
OpenEvidence Raises $200M at $6B Valuation to Scale Medical AI
Wealth.com Raises $65M Series B to Expand AI-Powered Wealth Management Platform
Counsel Health Raises $25M Series A Led by A16z and GV
Harvey Raises $300M Series E at $5B Valuation
Counsel Health Raises $25M Series A Led by A16z and GV